Gene name:
Protein name: Protein farnesyltransferase/geranylgeranyltransferase type-1
List of molecules and drugs that interact with protein J9VSJ6
# | DrugDomain Data | PBD ligand | DrugBank Accession | PubChem | ChEMBL | Name | Drug action | Affinity data |
---|---|---|---|---|---|---|---|---|
1 | J9VSJ6_3FX | 3FX | n/a | 7004983;7004984; | n/a | (2R)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid | n/a | |
2 | J9VSJ6_EDO | EDO | n/a | 174 | CHEMBL457299 | 1,2-ETHANEDIOL | n/a | |
3 | J9VSJ6_FII | FII | DB07771 | 445015 | n/a | [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID | n/a | |
4 | J9VSJ6_FPP | FPP | DB07780 | 445713 | CHEMBL69330 | FARNESYL DIPHOSPHATE | n/a | |
5 | J9VSJ6_SO4 | SO4 | DB14546 | 1117 | n/a | SULFATE ION | n/a | |
6 | J9VSJ6_XMV | XMV | n/a | 11756098 | CHEMBL5209874 | 4-{[5-({(2S)-2-butyl-5-oxo-4-[3-(trifluoromethoxy)phenyl]piperazin-1-yl}methyl)-1H-imidazol-1-yl]methyl}benzonitrile | n/a | |
7 | J9VSJ6_XMY | XMY | n/a | 165412423 | CHEMBL5182445 | (5S)-4-({1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl}methyl)-5-butyl-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one | n/a | |
8 | J9VSJ6_XN4 | XN4 | n/a | 165416318 | CHEMBL5171383 | (5S)-5-butyl-4-({1-[(4-chlorophenyl)methyl]-1H-imidazol-5-yl}methyl)-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one | n/a | |
9 | J9VSJ6_XO1 | XO1 | n/a | 165416316 | CHEMBL5189765 | 4-{[5-({(2S)-2-butyl-5-oxo-4-[3-(trifluoromethoxy)phenyl]piperazin-1-yl}methyl)-1H-imidazol-1-yl]methyl}-2-fluorobenzonitrile | n/a | |
10 | J9VSJ6_XO4 | XO4 | n/a | 165416317 | CHEMBL5171138 | (5S)-5-butyl-4-({1-[(4-fluorophenyl)methyl]-1H-imidazol-5-yl}methyl)-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one | n/a | |
11 | J9VSJ6_XO7 | XO7 | n/a | 165416319 | CHEMBL5182735 | (5S)-4-({1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl}methyl)-5-propyl-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one | n/a | |
12 | J9VSJ6_XOA | XOA | n/a | 165416320 | CHEMBL5197720 | (5S)-4-({1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl}methyl)-5-butyl-1-(3-chlorophenyl)piperazin-2-one | n/a |